These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15562531)

  • 1. Access to affordable drugs hinges on competition. Study notes lowest prices in India, South Africa.
    AIDS Alert; 2004 Nov; 19(11):129-30. PubMed ID: 15562531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A visit to India: drug prices, research, & global access.
    Scondras D
    AIDS Treat News; 1999 Jan; (No 311):6-8. PubMed ID: 11366155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Commentary: most South Africans cannot afford anti-HIV drugs.
    Achmat Z
    BMJ; 2002 Jan; 324(7331):217-8. PubMed ID: 11831204
    [No Abstract]   [Full Text] [Related]  

  • 4. Merck, Bristol-Myers Squibb announce major price reductions for poorest countries: major access progress but questions remain.
    James JS
    AIDS Treat News; 2001 Feb; (361):5-7. PubMed ID: 12765151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Access to essential drugs, human rights and global justice.
    Shalev C
    Monash Bioeth Rev; 2004 Jan; 23(1):S56-74. PubMed ID: 15835024
    [No Abstract]   [Full Text] [Related]  

  • 6. Access to essential medications for HIV/AIDS in South Africa.
    Andrews S
    S Afr Med J; 2001 May; 91(5):384-7. PubMed ID: 11455797
    [No Abstract]   [Full Text] [Related]  

  • 7. A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations.
    Pinheiro Edos S; Antunes OA; Fortunak JM
    Antiviral Res; 2008 Sep; 79(3):143-65. PubMed ID: 18571246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physicians say generic AIDS drugs don't threaten R&D.
    AIDS Policy Law; 2002 Mar; 17(6):4. PubMed ID: 12004757
    [No Abstract]   [Full Text] [Related]  

  • 9. Africa access: moving fast, outcome uncertain.
    James JS
    AIDS Treat News; 2001 Feb; (360):4-8. PubMed ID: 12173567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laboratory monitoring of HIV--after access to antiretroviral drugs, the next challenge for the developing world.
    Tucker T; Yeats J
    S Afr Med J; 2001 Aug; 91(8):615. PubMed ID: 11584766
    [No Abstract]   [Full Text] [Related]  

  • 11. Medicines for all, not just the rich.
    Davey S
    Bull World Health Organ; 2001; 79(4):377-8. PubMed ID: 11357220
    [No Abstract]   [Full Text] [Related]  

  • 12. The economics of effective AIDS treatment in Thailand.
    Over M; Revenga A; Masaki E; Peerapatanapokin W; Gold J; Tangcharoensathien V; Thanprasertsuk S
    AIDS; 2007 Jul; 21 Suppl 4():S105-16. PubMed ID: 17620745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generic drugs battle moves from South Africa to Kenya.
    Siringi S
    Lancet; 2001 May; 357(9268):1600. PubMed ID: 11377665
    [No Abstract]   [Full Text] [Related]  

  • 14. The (political) economics of antiretroviral treatment in developing countries.
    Nattrass NJ
    Trends Microbiol; 2008 Dec; 16(12):574-9. PubMed ID: 18964022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kenya says yes to generic ARVs but fails to win Global Fund cash.
    Njoroge J
    Bull World Health Organ; 2002; 80(7):608. PubMed ID: 12163933
    [No Abstract]   [Full Text] [Related]  

  • 16. Improving access to essential drugs for people living with HIV/AIDS.
    Balasubramaniam K
    Issues Med Ethics; 2000; 8(1):26-7. PubMed ID: 16323335
    [No Abstract]   [Full Text] [Related]  

  • 17. Ensuring access to essential medicines: some economic considerations.
    Maskus KE
    Spec Law Dig Health Care Law; 2003 Jul; (291):9-25. PubMed ID: 15206162
    [No Abstract]   [Full Text] [Related]  

  • 18. Affordable drug access for developing countries.
    Highleyman L
    BETA; 2001; 14(2):12-25. PubMed ID: 11702763
    [No Abstract]   [Full Text] [Related]  

  • 19. Africa finds drug giants guilty of excessive pricing.
    AIDS Policy Law; 2003 Dec; 18(22):5. PubMed ID: 14974397
    [No Abstract]   [Full Text] [Related]  

  • 20. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.
    't Hoen E
    Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.